Form 4: Colgate-Palmolive Director Nelson Receives Stock Grant and Option Award

Sentiment:

SEC Form 4 Filing


Director Kimberly A Nelson receives stock grant and option award from Colgate-Palmolive.

Summary

  • Kimberly A Nelson, a director of Colgate-Palmolive, reported a transaction on May 13, 2024.
  • Nelson received 1,905 shares of common stock as an annual director stock grant under the issuer's incentive compensation plan.
  • These shares were credited to a stock unit account.
  • Nelson also received an annual director stock option grant for 2,201 shares with an exercise price of $94.46.
  • The options become exercisable in equal annual installments over three years, starting May 13, 2025.
  • Following the reported transactions, Nelson directly owns 7,209 shares of common stock.
  • Nelson also indirectly owns shares through a family trust (575 shares), spouse (215 shares), and another trust (1,799 shares).

Sentiment

Score: 7

Explanation: The document reflects standard executive compensation practices, indicating stability and alignment of interests. It's a neutral-positive event.

Positives

  • The stock and option grants are part of Colgate-Palmolive's incentive compensation plan, aligning director interests with company performance.
  • The vesting schedule of the options encourages long-term commitment from the director.

Future Outlook

The director's holdings will increase as the options vest over the next three years.

Industry Context

Stock grants and options are common forms of executive compensation in publicly traded companies, aligning management's interests with those of shareholders.

Stakeholder Impact

  • The stock and option grants align the director's interests with those of shareholders, potentially leading to decisions that benefit the company's long-term performance.

Key Dates

DateDescription
05/13/2024Date of the stock grant and option award.
05/13/2025First anniversary of the grant date, when the options begin to vest.
05/13/2032Expiration date of the stock options.
05/15/2024Date of signature for the filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.